Reddy R, Pannu S, Fiumara K, Kahn J, et al. Efficacy of in-class IL-23 inhibitor switching: Risankizumab following Guselkumab failure in moderate-to-severe psoriasis treatment. Br J Dermatol 2020 Sep 30. doi: 10.1111/bjd.19575.
PMID: 32998185